No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
364 |
4. Check minimum number of eventsNone |
364 |
5. Include endpointsNone |
364 |
6. Filter based on genotype QC (FinnGen only) |
364 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF7
Similar endpoints
↥List of similar endpoints to
Previous suicide attempt
based on the number of shared cases.
Similar with more cases:
- Personal history of risk-factors, not elsewhere classified
- Persons with potential health hazards related to family and personal history and certain conditions influencing health status
- Factors influencing health status and contact with health services
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3610 | 1924 | 1673 |
| Only index persons | 3305 | 1828 | 1477 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.06 | 0.05 |
| Only index persons | 0.06 | 0.07 | 0.06 |
| Median age at first event (years) | |||
| Whole population | 30.26 | 24.62 | 36.62 |
| Only index persons | 29.01 | 23.99 | 35.22 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 364 | 228 | 136 |
| Unadjusted period prevalence (%) | 0.07 | 0.08 | 0.06 |
| Median age at first event (years) | 35.09 | 30.14 | 43.41 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 321
- Matched controls
- 3209
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z91.5
ICD-10 Finland
Personal history of self-harm
4503599627370496.0
323.0
317
*
T36
ICD-10 Finland
Poisoning by systemic antibiotics
62.1
170.9
202
85
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
71.6
165.0
187
61
F32.9
ICD-10 Finland
Depressive episode, unspecified
22.1
126.2
224
303
N05AH04
ATC
quetiapine; oral
18.6
115.8
226
363
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
19.0
84.9
140
125
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
35.4
81.2
106
44
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
19.7
80.7
130
107
N05AH03
ATC
olanzapine; systemic
18.3
77.2
128
112
N05BA04
ATC
oxazepam; oral
8.7
66.5
190
459
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
14.1
65.2
121
132
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
33.5
63.1
83
33
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
51.1
60.4
72
18
N05AX08
ATC
risperidone; systemic
13.0
57.1
109
122
N05AA02
ATC
levomepromazine; systemic
19.8
57.1
89
61
N06AX16
ATC
venlafaxine; oral
8.6
57.0
148
290
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
14.5
55.8
100
97
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
30.1
54.1
73
31
N06AX11
ATC
mirtazapine; oral
6.5
52.1
195
620
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
8.3
52.0
135
258
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
16.0
51.8
88
74
N05AX12
ATC
aripiprazole; systemic
15.6
51.8
89
77
N07BB01
ATC
disulfiram; oral
17.7
51.7
84
63
F29
ICD-10 Finland
Unspecified nonorganic psychosis
15.1
50.0
87
77
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
8.6
49.0
121
210
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
29.3
48.7
66
28
N05BA01
ATC
diazepam; systemic, rectal
9.0
48.2
114
184
N03AX09
ATC
lamotrigine; oral
12.7
45.6
86
90
N06AB06
ATC
sertraline; oral
7.8
44.0
116
218
Z72.8
ICD-10 Finland
Other problems related to lifestyle
80.2
43.4
48
7
N06AB03
ATC
fluoxetine; oral
7.5
43.3
117
227
N05AF03
ATC
chlorprothixene; systemic
19.4
43.3
67
43
N06AB04
ATC
citalopram; systemic
6.3
42.8
139
346
N05CF01
ATC
zopiclone; oral
5.7
42.6
162
489
N05CD07
ATC
temazepam; oral
10.5
42.6
89
113
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
10.3
42.1
89
115
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
7.2
41.2
114
227
N03AG01
ATC
valproic acid; systemic, rectal
10.1
40.7
87
114
F10.20
ICD-10 Finland
Alcohol dependence currently independent
24.5
40.0
57
28
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
27.4
40.0
55
24
F60.9
ICD-10 Finland
Personality disorder, unspecified
27.4
40.0
55
24
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
16.4
38.3
63
47
C07AA05
ATC
propranolol; systemic
5.5
37.0
135
374
X78
ICD-10 Finland
Intentional self-harm by sharp object
50.7
37.0
44
10
N06AB10
ATC
escitalopram; oral
5.0
35.8
148
468
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
30.5
33.9
45
17
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
13.7
33.8
60
53
P29
ICPC
Psychological sympt/compl other
7.8
33.3
83
137
N05AB03
ATC
perphenazine; systemic, rectal
14.8
32.8
56
45
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
13.3
31.9
57
51
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
5.7
31.2
102
241
N05BA06
ATC
lorazepam; systemic, sublingual
14.5
30.9
53
43
IGY99
NOMESCO Finland
Other psychiatric treatment contact
17.4
30.2
48
32
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
63.0
29.8
34
6
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
19.4
28.9
44
26
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
21.8
28.7
42
22
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
25.2
28.6
40
18
P15
ICPC
Chronic alcohol abuse
15.1
28.5
48
37
F61.0
ICD-10 Finland
Mixed personality disorders
19.7
28.4
43
25
N05AN01
ATC
lithium; oral
13.6
28.4
50
43
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
85.6
28.3
31
*
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
11.4
28.0
54
56
N03AE01
ATC
clonazepam; systemic
9.3
27.8
60
77
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
12.0
27.7
52
51
F10.09
ICD-10 Finland
Alcohol intoxication UNS
18.2
27.6
43
27
N06AX12
ATC
bupropion; oral
7.1
27.4
72
126
N05AD01
ATC
haloperidol; systemic
15.2
26.9
45
34
N05BE01
ATC
buspirone; oral
15.3
26.4
44
33
IAB08
NOMESCO Finland
Consultation concerning a patient who has attempted suicide
79.2
26.2
29
*
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
18.9
26.1
40
24
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
101.9
26.1
28
*
X84
ICD-10 Finland
Intentional self-harm by unspecified means
146.8
26.0
27
*
F10.24
ICD-10 Finland
Alcohol depence active use
31.5
26.0
34
12
ZY010
NOMESCO Finland
Hospital outpatient
7.4
25.5
64
104
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
20.7
25.0
37
20
AA400
NOMESCO Finland
Electroconvulsive therapy
41.1
24.4
30
8
AA1AD
NOMESCO Finland
CT of head and brain
4.4
24.2
104
318
IGV01
NOMESCO Finland
Psychiatric network contact
34.1
24.2
31
10
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
27.2
23.6
32
13
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
3.7
23.2
128
486
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
29.9
22.7
30
11
SPAT1240
SPAT
Therapeutic discussion
4.3
22.6
98
300
IAB07
NOMESCO Finland
Consultation concerning a patient with self-harm intention
67.5
22.2
25
*
Z2446
NOMESCO Finland
Social worker
6.0
22.1
65
130
ZY000
NOMESCO Finland
Hospital inpatient
13.7
22.0
38
31
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
12.5
21.6
39
35
S06.0
ICD-10 Finland
Concussion
4.9
21.5
78
199
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
14.3
21.3
36
28
P99
ICPC
Psychological disorders other
9.8
20.9
43
50
N06AX21
ATC
duloxetine; oral
5.2
20.8
69
159
F99
ICD-10 Finland
Mental disorder, not otherwise specified
13.4
20.6
36
30
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
6.8
20.5
54
93
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
15.2
20.0
33
24
IGY02
NOMESCO Finland
Psychiatric monitoring contact
11.8
20.0
37
35
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
7.3
19.5
48
75
P01
ICPC
Feeling anxious/nervous/tense
3.7
19.4
100
348
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
5.5
19.3
61
132
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.7
19.3
71
182
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
36.9
19.2
24
7
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
5.3
18.8
61
136
F31.8
ICD-10 Finland
Other bipolar affective disorders
10.3
18.7
37
40
F39
ICD-10 Finland
Unspecified mood [affective] disorder
10.3
18.7
37
40
N05AH02
ATC
clozapine; systemic
10.8
18.7
36
37
N06AB05
ATC
paroxetine; oral
6.4
18.7
51
92
ZYC01
NOMESCO Finland
Remote contact by phone
7.4
18.5
45
69
N06AA12
ATC
doxepin; systemic
11.1
18.4
35
35
N06AX03
ATC
mianserin; oral
9.1
18.4
39
48
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.0
18.3
158
792
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
17.9
18.2
28
17
ICC03
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric ward
55.9
18.2
21
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.9
18.0
84
268
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
24.5
18.0
25
11
TKC20
NOMESCO Finland
Catheterisation of bladder
7.8
17.9
42
61
N05BA02
ATC
chlordiazepoxide; systemic
14.3
17.8
30
23
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
20.1
17.6
26
14
F10.25
ICD-10 Finland
Alcohol dependence continuous use
13.7
17.5
30
24
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
33.6
17.3
22
7
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
18.7
17.2
26
15
F43.1
ICD-10 Finland
Post-traumatic stress disorder
8.5
17.2
38
50
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
10.7
17.1
33
34
A02BC02
ATC
pantoprazole; systemic
2.8
17.1
212
1314
N05BA12
ATC
alprazolam; oral
4.8
17.0
60
146
WX892
NOMESCO Finland
Monitored bed care
5.9
16.9
49
95
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
12.6
16.9
30
26
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
12.6
16.9
30
26
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
11.3
16.6
31
30
R11
ICD-10 Finland
Nausea and vomiting
5.0
16.6
56
130
F20.9
ICD-10 Finland
Schizophrenia, unspecified
10.3
16.3
32
34
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
31.9
16.3
21
7
N03AX16
ATC
pregabalin; oral
3.2
16.2
101
401
R56.8
ICD-10 Finland
Other and unspecified convulsions
5.4
16.0
50
106
F34.1
ICD-10 Finland
Dysthymia
7.4
15.8
38
57
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
6.1
15.8
44
81
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
23.5
15.8
22
10
F41.1
ICD-10 Finland
Generalized anxiety disorder
5.0
15.4
51
116
Z72.2
ICD-10 Finland
Drug use
21.4
15.3
22
11
V03AA01
ATC
NA
24.8
15.3
21
9
XF400
NOMESCO Finland
ECG with 12 standard connections
3.9
15.2
68
207
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
10.5
15.0
29
30
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
59.6
14.9
17
*
IEY08
NOMESCO Finland
Psychiatric coaching, domestic and community skills
59.6
14.9
17
*
A06AD11
ATC
lactulose; oral
4.7
14.9
53
130
P06
ICPC
Sleep disturbance
4.2
14.8
60
167
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
6.8
14.6
37
60
IEV99
NOMESCO Finland
Other psychiatric network intervention
38.0
14.6
18
5
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
5.1
14.5
47
104
N06AX05
ATC
trazodone; oral
8.7
14.4
31
39
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
20.3
14.4
21
11
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
5.7
14.4
42
82
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
55.9
13.9
16
*
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
8.6
13.9
30
38
P74
ICPC
Anxiety disorder/anxiety state
5.5
13.9
42
86
P03
ICPC
Feeling depressed
3.3
13.8
76
272
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
9.5
13.8
28
32
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
15.6
13.8
22
15
P16
ICPC
Acute alcohol abuse
11.7
13.8
25
23
N06AX22
ATC
agomelatine; oral
10.8
13.7
26
26
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
35.7
13.6
17
5
F41.8
ICD-10 Finland
Other specified anxiety disorders
6.6
13.6
35
58
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
13.6
131
670
R07.4
ICD-10 Finland
Chest pain, unspecified
3.0
13.6
91
372
IEY01
NOMESCO Finland
Psychoeducation, individual
19.3
13.5
20
11
F60.8
ICD-10 Finland
Other specific personality disorders
19.3
13.5
20
11
R55
ICD-10 Finland
Syncope and collapse
4.6
13.5
49
122
N05AA01
ATC
chlorpromazine; systemic, rectal
14.7
13.4
22
16
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
5.8
13.2
38
73
N06AX26
ATC
vortioxetine; oral
4.8
13.2
45
105
SPAT1301
SPAT
No procedures
2.6
13.2
124
625
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.7
13.2
46
110
C07AB07
ATC
bisoprolol; oral
2.6
13.1
121
602
N04AA02
ATC
biperiden; systemic
9.1
13.1
27
32
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.9
13.0
94
402
TPH04
NOMESCO Finland
Cathetrisation of vein
3.1
13.0
83
329
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
4.9
12.9
43
98
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
5.1
12.9
41
89
M54.5
ICD-10 Finland
Low back pain
2.5
12.8
132
695
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
7.9
12.8
29
40
T74.1
ICD-10 Finland
Physical abuse
9.9
12.7
25
27
T90
ICPC
Diabetes non-insulin dependent
3.3
12.7
70
250
F33.8
ICD-10 Finland
Other recurrent depressive disorders
18.2
12.7
19
11
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
3.1
12.7
77
294
WX290
NOMESCO Finland
Other blockade of nerve
2.4
12.6
195
1264
N03AX12
ATC
gabapentin; oral
3.4
12.6
68
238
R53
ICD-10 Finland
Malaise and fatigue
2.8
12.6
93
405
N06AA09
ATC
amitriptyline; systemic
4.5
12.5
46
116
X59
ICD-10 Finland
Exposure to unspecified factor
2.8
12.5
92
400
N05AF01
ATC
flupentixol; systemic
16.7
12.3
19
12
Z72.1
ICD-10 Finland
Alcohol use
16.7
12.3
19
12
R51.80
ICD-10 Finland
Headache
2.9
12.3
83
341
K59.09
ICD-10 Finland
Constipation, unspecified
6.6
12.2
31
51
IBZ02
NOMESCO Finland
Somatic assessment of psychiatric patient
27.9
12.2
16
6
F61
ICD-10 Finland
Mixed and other personality disorders
27.9
12.2
16
6
SPAT1227
SPAT
Substance abuse rehabilitation
22.3
12.1
17
8
N05CF02
ATC
zolpidem; oral
3.0
12.1
79
317
C07AB02
ATC
metoprolol; systemic
3.5
12.1
60
198
N05AE04
ATC
ziprasidone; systemic
17.2
11.8
18
11
IER01
NOMESCO Finland
Psychoeducation, group
17.2
11.8
18
11
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
23.9
11.7
16
7
F92.0
ICD-10 Finland
Depressive conduct disorder
23.9
11.7
16
7
Z2445
NOMESCO Finland
Psychologist
4.8
11.6
39
90
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
5.7
11.6
33
63
R33
ICD-10 Finland
Retention of urine
6.1
11.5
31
55
F93.89
ICD-10 Finland
Other childhood emotional disorders
12.5
11.5
20
17
N02AX02
ATC
tramadol; systemic, rectal
2.4
11.5
136
758
F41.09
ICD-10 Finland
UNS Panic Syndrome
6.9
11.4
28
44
C03CA01
ATC
furosemide; systemic
3.3
11.3
62
219
SPAT1254
SPAT
Administration of medicine
3.0
11.3
70
269
R52.9
ICD-10 Finland
Pain, unspecified
4.2
11.3
44
118
ZXY49
NOMESCO Finland
Other health care provider
20.9
11.2
16
8
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
26.1
11.2
15
6
A01
ICPC
Pain general/multiple sites
4.2
11.2
43
113
D12
ICPC
Constipation
9.1
11.2
23
27
S61.8
ICD-10 Finland
Open wound of other parts of wrist and hand
9.8
11.2
22
24
P76
ICPC
Depressive disorder
3.7
11.2
51
157
Z3231
NOMESCO Finland
Registered nurse
2.5
11.1
104
511
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
6.9
11.1
27
42
P77
ICPC
Suicide/suicide attempt
44.9
11.0
13
*
F60.0
ICD-10 Finland
Paranoid personality disorder
44.9
11.0
13
*
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.8
11.0
78
328
Z00.0
ICD-10 Finland
General medical examination
2.8
10.9
80
340
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
11.1
10.9
20
19
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
8.0
10.9
24
32
SPAT1234
SPAT
Support of social functional capacity
6.4
10.9
28
47
188
Kela drug reimbursment
Psychosis requiring demanding treatment
29.1
10.8
14
5
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
22.4
10.8
15
7
SPAT1243
SPAT
Psychiatric/psychological examination
5.8
10.7
30
56
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
9.0
10.7
22
26
NA1AD
NOMESCO Finland
Cervical spine CT examination
6.3
10.7
28
48
T65.9
ICD-10 Finland
Toxic effect: Toxic effect of unspecified substance
62.1
10.7
12
*
N06CA01
ATC
amitriptyline and psycholeptics; systemic
4.1
10.6
42
114
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
14.9
10.6
17
12
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.9
10.6
70
281
N06AB08
ATC
fluvoxamine; oral
8.7
10.5
22
27
S18
ICPC
Laceration/cut
2.3
10.5
138
802
ZXY60
NOMESCO Finland
2-person team, nurses
12.6
10.5
18
15
X61
ICD-10 Finland
Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified
33.7
10.4
13
*
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
33.7
10.4
13
*
TPH07
NOMESCO Finland
Cathetrisation of artery
4.1
10.4
41
111
XF600
NOMESCO Finland
Bloodpressure measurement
4.9
10.2
33
73
B18.2
ICD-10 Finland
Chronic viral hepatitis C
9.6
10.2
20
22
W19
ICD-10 Finland
Unspecified fall
3.6
10.2
47
146
F31
ICD-10 Finland
Bipolar affective disorder
10.5
10.2
19
19
SPAT1249
SPAT
Treatment-related counselling outside office
2.2
10.1
150
917
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
15.2
10.1
16
11
SPAT1260
SPAT
Consultation of another employee
2.7
10.0
75
322
N05AC02
ATC
thioridazine; oral
8.6
10.0
21
26
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
4.8
10.0
33
75
F40.1
ICD-10 Finland
Social phobias
6.2
9.9
26
45
N05AD03
ATC
melperone; systemic
27.0
9.9
13
5
IEY21
NOMESCO Finland
Other intensified psychiatric treatment
27.0
9.9
13
5
ZYD01
NOMESCO Finland
Emergency clinic
27.0
9.9
13
5
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
27.0
9.9
13
5
S29
ICPC
Skin symptom/complaint other
2.8
9.9
67
273
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
20.8
9.9
14
7
A06AC01
ATC
ispaghula (psylla seeds); oral
2.7
9.8
74
320
F50.9
ICD-10 Finland
Eating disorder, unspecified
8.2
9.8
21
27
X58
ICD-10 Finland
Exposure to other specified factors
2.7
9.7
75
330
N03AX11
ATC
topiramate; oral
6.4
9.7
25
42
N02BE01
ATC
paracetamol; systemic, rectal
2.5
9.7
269
2161
SPAT1310
SPAT
Counselling related to known health issue
2.2
9.7
124
703
S51.9
ICD-10 Finland
Open wound of forearm, part unspecified
8.8
9.7
20
24
F23.99
ICD-10 Finland
Acute and transient psychosis, unspecified UNS
56.7
9.7
11
*
P18
ICPC
Medication abuse
11.9
9.7
17
15
P72
ICPC
Schizophrenia
9.5
9.7
19
21
R05
ICPC
Cough
2.5
9.7
90
439
EBA05
NOMESCO Finland
Complicated extraction of tooth
2.6
9.6
78
350
R50.9
ICD-10 Finland
Fever, unspecified
2.9
9.6
61
237
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.4
9.6
48
159
Z71.8
ICD-10 Finland
Other specified counselling
2.3
9.6
105
556
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
5.2
9.6
29
60
F10.02
ICD-10 Finland
Alcohol-related acute intoxication with other acute clinical complications
102.9
9.5
10
*
RS220
NOMESCO Finland
NA
12.9
9.5
16
13
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
9.1
9.4
19
22
P73
ICPC
Affective psychosis
22.5
9.4
13
6
N03AF01
ATC
carbamazepine; oral, rectal
5.3
9.4
28
57
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.5
9.4
86
415
F51.0
ICD-10 Finland
Nonorganic insomnia
2.7
9.4
69
294
R06.0
ICD-10 Finland
Dyspnoea
2.6
9.3
79
364
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
2.1
9.3
179
1209
F05.9
ICD-10 Finland
Delirium, unspecified
14.2
9.3
15
11
D11
ICPC
Diarrhoea
2.9
9.3
60
237
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.9
9.2
62
248
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.1
9.2
53
194
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.3
9.2
47
158
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.8
9.2
39
113
M79.6
ICD-10 Finland
Pain in limb
2.2
9.2
127
745
WX110
NOMESCO Finland
Local anesthesy
2.2
9.1
245
1899
S10
ICPC
Boil/carbuncle
4.8
9.1
30
68
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.6
9.1
73
326
F41.00
ICD-10 Finland
Moderate panic disorder
7.8
9.1
20
27
ZXY56
NOMESCO Finland
2-person team, nurse-psychologist
37.8
9.1
11
*
Y19
ICD-10 Finland
Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent
37.8
9.1
11
*
F10.22
ICD-10 Finland
Alcohol dependence is currently on clinically controlled discontinuation medication
37.8
9.1
11
*
ZYY79
NOMESCO Finland
Other indirect service without contact with patient
19.3
9.0
13
7
F10.01
ICD-10 Finland
Alcohol-related acute intoxication with permanent or other somatic damage
24.8
9.0
12
5
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.8
9.0
61
247
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
8.0
8.8
19
25
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
14.6
8.8
14
10
103
Kela drug reimbursment
Diabetes, insulin-treated
2.5
8.8
74
341
F32.1
ICD-10 Finland
Moderate depressive episode
3.4
8.7
43
141
A02BC03
ATC
lansoprazole; oral
2.4
8.7
86
428
K92.0
ICD-10 Finland
Haematemesis
12.0
8.7
15
13
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
9.4
8.6
17
19
P27
ICPC
Fear of mental disorder
9.4
8.6
17
19
F32
ICD-10 Finland
Depressive episode
3.7
8.6
37
109
A02BC01
ATC
omeprazole; systemic
2.3
8.5
91
469
EBA00
NOMESCO Finland
Extraction of tooth
2.1
8.5
130
786
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
28.4
8.5
11
*
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
28.4
8.5
11
*
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
20.7
8.5
12
6
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.0
8.5
152
985
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.3
8.5
98
524
A03FA01
ATC
metoclopramide; systemic, rectal
2.5
8.5
70
318
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
5.6
8.5
24
46
F19.09
ICD-10 Finland
Intoxication caused by several drugs in combination and by other psychoactive substances UNS
92.4
8.5
9
*
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
13.2
8.4
14
11
Z3226
NOMESCO Finland
Physiotherapist
2.6
8.4
69
310
G43.9
ICD-10 Finland
Migraine, unspecified
3.4
8.3
41
134
R42
ICD-10 Finland
Dizziness and giddiness
2.5
8.3
69
314
N30.0
ICD-10 Finland
Acute cystitis
2.9
8.3
54
212
A10BA02
ATC
metformin; oral
2.4
8.3
75
356
F25.20
ICD-10 Finland
Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms
15.0
8.3
13
9
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
15.0
8.3
13
9
K04.0
ICD-10 Finland
Pulpitis
2.9
8.2
51
196
A46
ICD-10 Finland
Erysipelas
3.2
8.2
43
148
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
12.1
8.1
14
12
S51.8
ICD-10 Finland
Open wound of other parts of forearm
17.7
8.1
12
7
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
17.7
8.1
12
7
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
10.4
8.1
15
15
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
22.7
8.1
11
5
R44.0
ICD-10 Finland
Auditory hallucinations
22.7
8.1
11
5
N06AA06
ATC
trimipramine; systemic
6.9
8.0
19
29
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.7
8.0
34
99
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
6.0
8.0
21
37
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.1
8.0
45
162
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.4
8.0
76
372
S01.0
ICD-10 Finland
Open wound of scalp
3.8
8.0
33
94
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
13.5
7.9
13
10
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.0
7.9
31
84
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
8.8
7.9
16
19
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
11.2
7.9
14
13
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
9.8
7.9
15
16
K92.1
ICD-10 Finland
Melaena
5.5
7.8
22
42
A03
ICPC
Fever
2.3
7.8
81
413
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
15.5
7.8
12
8
S09.9
ICD-10 Finland
Unspecified injury of head
15.5
7.8
12
8
N71.0
ICD-10 Finland
Acute inflammatory disease of uterus
5.2
7.8
23
47
F13.20
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent
46.1
7.7
9
*
IEY15
NOMESCO Finland
Acute psychiatry, stabilising intervention
46.1
7.7
9
*
Y34
ICD-10 Finland
Unspecified event, undetermined intent
46.1
7.7
9
*
F10.3
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Withdrawal state
46.1
7.7
9
*
L17
ICPC
Foot/toe symptom/complaint
2.2
7.7
88
466
G47.3
ICD-10 Finland
Sleep apnoea
2.5
7.7
65
297
F43.00
ICD-10 Finland
Acute stress reaction mild
5.4
7.7
22
43
A02BA02
ATC
ranitidine; systemic
2.6
7.7
58
251
T51.0
ICD-10 Finland
Toxic effect: Ethanol
18.9
7.6
11
6
F21
ICD-10 Finland
Schizotypal disorder
18.9
7.6
11
6
SPAT1265
SPAT
Breathalyser
9.2
7.6
15
17
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.8
7.6
51
205
F34.0
ICD-10 Finland
Cyclothymia
25.7
7.6
10
*
Z86.4
ICD-10 Finland
Personal history of psychoactive substance abuse
25.7
7.6
10
*
IAB11
NOMESCO Finland
Psychiatric mood consultation
25.7
7.6
10
*
N07BA03
ATC
varenicline; oral
3.9
7.6
30
82
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
3.5
7.6
35
109
A28
ICPC
Limited function/disability NOS
3.3
7.6
37
121
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.7
7.5
51
207
X57
ICD-10 Finland
Unspecified privation
6.7
7.5
18
28
N92.6
ICD-10 Finland
Irregular menstruation, unspecified
3.4
7.5
35
110
Z00.8
ICD-10 Finland
Other general examinations
3.1
7.5
40
139
U05
ICPC
Urination problems other
5.9
7.5
20
36
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
8.0
7.5
16
21
R03BB04
ATC
tiotropium bromide; inhalant
3.7
7.5
32
94
9694A
ICD-9 Finland
Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers
13.8
7.4
12
9
IGP01
NOMESCO Finland
Psychiatric family contact
13.8
7.4
12
9
R02
ICPC
Shortness of breath/dyspnoea
2.8
7.4
47
183
L03
ICPC
Low back symptom/complaint
2.2
7.4
88
476
E66.01
ICD-10 Finland
Obesity due to excess calories
3.3
7.4
37
123
D01
ICPC
Abdominal pain/cramps general
2.6
7.4
55
233
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.9
7.4
148
986
K04.08
ICD-10 Finland
Other specified pulpit
3.2
7.4
38
129
Y94.0
ICD-10 Finland
Accident at home
11.2
7.4
13
12
S50.1
ICD-10 Finland
Contusion of other and unspecified parts of forearm
11.2
7.4
13
12
N05AF05
ATC
zuclopenthixol; systemic
11.2
7.4
13
12
SAA01
NOMESCO Finland
Simple examination of mouth
2.1
7.3
250
2020
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.2
7.3
89
485
J01FF01
ATC
clindamycin; systemic
2.1
7.2
92
513
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
8.2
7.2
15
19
N06AA22
ATC
NA
30.8
7.2
9
*
IDR03
NOMESCO Finland
Systematic group therapy, dialectical behaviour therapy (DBT)
30.8
7.2
9
*
ZXY59
NOMESCO Finland
2-person team, nurse-other special worker
30.8
7.2
9
*
F19.00
ICD-10 Finland
Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated
30.8
7.2
9
*
F19.2
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome
30.8
7.2
9
*
R44.3
ICD-10 Finland
Hallucinations, unspecified
20.6
7.2
10
5
IEY06
NOMESCO Finland
Psychiatric treatment and rehabilitation coaching
20.6
7.2
10
5
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
12.4
7.1
12
10
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
2.0
7.1
122
764
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.0
7.1
116
710
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.8
7.1
46
182
SPAT1307
SPAT
Psychosocial counselling and guidance
2.7
7.0
50
206
SPAT1312
SPAT
General health counselling
1.9
7.0
131
845
-1
NOMESCO Finland
NA
1.9
7.0
140
923
R4120
NOMESCO Finland
Occupational therapy
3.7
7.0
29
83
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.5
7.0
31
94
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.9
7.0
27
73
D02
ICPC
Abdominal pain epigastric
3.7
6.9
29
84
N05AL01
ATC
sulpiride; systemic
8.6
6.9
14
17
H01
ICPC
Ear pain/earache
2.5
6.9
53
231
SPAT1262
SPAT
Handing over of treatment supplies
2.5
6.9
55
243
J45.9
ICD-10 Finland
Asthma, unspecified
2.3
6.9
65
316
N01
ICPC
Headache
2.4
6.9
62
292
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.6
6.9
52
223
Z08
ICPC
Social welfare problem
11.3
6.8
12
11
R41.0
ICD-10 Finland
Disorientation, unspecified
9.6
6.8
13
14
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
9.6
6.8
13
14
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.0
6.8
39
142
ZXD05
NOMESCO Finland
Urgent procedure
2.0
6.8
114
705
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.7
6.8
28
80
ZXY57
NOMESCO Finland
2-person team, nurse-social worker
40.9
6.8
8
*
IEZ99
NOMESCO Finland
Other psychiatric rehabilitation intervention
17.1
6.8
10
6
ZYY01
NOMESCO Finland
Contact between professionals
17.1
6.8
10
6
ZXY83
NOMESCO Finland
Social worker in multidisciplinary team
17.1
6.8
10
6
Y28
ICD-10 Finland
Contact with sharp object, undetermined intent
17.1
6.8
10
6
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
7.4
6.8
15
21
SPAT1241
SPAT
Extensive assessment of psychosocial situation
7.4
6.8
15
21
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
4.1
6.7
25
65
N06AG02
ATC
moclobemide; oral
5.4
6.7
19
37
A04
ICPC
Weakness/tiredness general
2.5
6.7
55
248
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.1
6.7
36
126
3050A
ICD-9 Finland
Nondependent abuse of drugs, Alcohol abuse
23.1
6.7
9
*
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
23.1
6.7
9
*
F23.3
ICD-10 Finland
Other acute predominantly delusional psychotic disorders
23.1
6.7
9
*
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
3.1
6.7
37
130
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.5
6.7
54
242
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
12.6
6.6
11
9
RS221
NOMESCO Finland
NA
9.0
6.6
13
15
SPAT1263
SPAT
Sampling
1.9
6.6
148
1012
D06
ICPC
Abdominal pain localized other
3.0
6.6
37
133
R07.3
ICD-10 Finland
Other chest pain
3.2
6.5
32
106
S14
ICPC
Burn/scald
4.4
6.4
22
53
T11.1
ICD-10 Finland
Open wound of upper limb, level unspecified
71.2
6.4
7
*
3092E
ICD-9 Finland
Adjustment reaction, With predominant disturbance of other emotions[USEINA EMOTIONAALISINA OIREINA ILM.SOPEUTUMISHÄIRIÖ]
71.2
6.4
7
*
IER03
NOMESCO Finland
Psychiatric disorder-specific group intervention
14.7
6.4
10
7
Z04.4
ICD-10 Finland
Examination and observation following alleged rape and seduction
14.7
6.4
10
7
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
14.7
6.4
10
7
A29
ICPC
General symptom/complaint other
2.9
6.4
40
152
L15
ICPC
Knee symptom/complaint
2.2
6.4
66
332
N05CD02
ATC
nitrazepam; oral
8.4
6.4
13
16
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.1
6.4
33
113
ICC01
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric outpatient clinic
11.3
6.3
11
10
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
9.5
6.3
12
13
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
4.3
6.3
22
54
Z2221
NOMESCO Finland
Medical doctor
2.0
6.3
97
578
IEY19
NOMESCO Finland
Psychiatric health counselling and guidance
18.5
6.3
9
5
R40.2
ICD-10 Finland
Coma, unspecified
18.5
6.3
9
5
U04
ICPC
Incontinence urine
5.2
6.3
18
36
R96
ICPC
Asthma
3.0
6.3
35
124
IBZ07
NOMESCO Finland
Neurological assessment in psychiatry
+∞
6.3
6
*
F10.06
ICD-10 Finland
Alcohol-related acute intoxication with seizures
+∞
6.3
6
*
F20.8
ICD-10 Finland
Other schizophrenia
27.2
6.3
8
*
F13.3
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state
27.2
6.3
8
*
ZXY52
NOMESCO Finland
2-person team, doctor-psychologist
27.2
6.3
8
*
F44.7
ICD-10 Finland
Mixed dissociative [conversion] disorders
27.2
6.3
8
*
XKD00
NOMESCO Finland
Uroflowmetry
2.9
6.3
36
132
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.6
6.2
46
195
Z72.0
ICD-10 Finland
Tobacco use
5.5
6.2
17
32
WX882
NOMESCO Finland
High dependency care
5.5
6.2
17
32
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.1
6.2
33
115
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
3.7
6.2
25
71
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
3.3
6.1
29
93
S00.8
ICD-10 Finland
Superficial injury of other parts of head
8.9
6.1
12
14
F22.0
ICD-10 Finland
Delusional disorder
10.3
6.1
11
11
R4140
NOMESCO Finland
Psychotherapy
10.3
6.1
11
11
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
3.5
6.1
27
83
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.8
6.0
38
146
R20.2
ICD-10 Finland
Paraesthesia of skin
3.1
6.0
32
112
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.5
6.0
45
193
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.5
6.0
26
78
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4198724)
70
20
43.10
113.75
3.6
2.3
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
60
10
71.64
109.31
5.9
2.9
umol/l
204.5
125.0
—
35
5
(3028707) Methadone [Presence] in Urine by Screen method
107
129
11.33
86.97
4.1
1.9
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
126
216
8.39
76.24
3.7
1.6
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
55
29
22.16
71.52
2.6
1.3
promille
1.7
1.4
0.46
45
22
(3016879) Cocaine [Presence] in Urine
131
251
7.59
71.10
3.9
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
114
195
8.06
68.56
3.4
2.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
132
265
7.25
68.22
3.9
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
132
269
7.13
67.12
3.9
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
130
267
7.02
65.44
3.9
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
129
267
6.93
64.33
3.9
1.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
176
500
5.88
62.15
3.4
1.8
%
1.7
1.4
6.00
161
457
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
246
963
5.80
58.55
5.9
3.1
u/l
29.4
31.0
0.29
238
917
(3009466) Valproate [Moles/volume] in Serum or Plasma
52
44
13.62
52.59
7.4
5.6
umol/l
379.9
373.8
0.08
45
39
(3003396) Base excess in Arterial blood by calculation
101
212
6.21
48.54
8.4
9.7
mmol/l
0.9
0.9
0.07
75
166
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
206
807
4.58
45.92
5.6
2.5
u/l
48.9
54.5
2.59
198
751
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
68
102
7.97
44.97
8.3
14.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
270
1314
5.08
44.48
8.5
5.7
umol/l
8.6
10.8
4.91
260
1243
(3002032) Base excess in Venous blood by calculation
91
188
6.12
44.20
5.2
4.0
mmol/l
1.5
1.4
0.03
77
139
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
97
214
5.82
43.89
8.6
9.5
kpa
5.1
5.1
0.12
97
205
(3027801) Oxygen [Partial pressure] in Arterial blood
97
214
5.82
43.89
8.6
9.5
kpa
10.8
13.2
4.58
97
206
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
230
1011
4.46
43.01
8.5
5.8
mmol/l
1.2
1.2
1.36
220
935
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
241
1118
4.42
41.27
10.0
6.6
mmol/l
1.2
1.2
1.12
215
948
(3000991) Gas panel - Venous blood
80
174
5.61
36.35
9.3
8.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
154
564
4.00
35.91
5.9
4.0
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
93
240
4.86
34.52
8.5
6.3
mmol/l
104.8
104.4
0.35
83
234
(3021960) Folate [Moles/volume] in Serum or Plasma
146
534
3.90
33.78
1.7
1.4
nmol/l
16.0
20.6
4.64
138
468
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
113
348
4.26
33.28
2.4
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
89
236
4.67
31.76
2.3
1.7
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
170
715
3.58
31.39
3.7
3.0
mmol/l
6.5
8.5
4.61
144
630
(3013826) Glucose [Moles/volume] in Serum or Plasma
270
1521
4.00
31.38
9.8
4.5
mmol/l
6.4
6.4
0.19
264
1357
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
88
237
4.58
30.72
2.4
1.7
—
—
—
0
0
(3018418) pH of Serum or Plasma
161
668
3.53
30.14
4.4
3.3
ph
7.4
7.4
0.92
33
120
(3032080) INR in Blood by Coagulation assay
184
831
3.46
30.02
8.9
6.5
inr
1.0
1.1
1.47
76
273
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
317
2054
5.21
28.85
11.6
6.5
u/l
77.7
75.6
0.42
310
1928
(3024561) Albumin [Mass/volume] in Serum or Plasma
201
977
3.36
28.73
6.8
4.6
g/l
35.5
37.0
2.83
191
916
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
121
431
3.71
28.45
1.7
1.5
pmol/l
117476176.9
17725305.1
0.39
103
378
(3047181) Lactate [Moles/volume] in Blood
45
71
7.09
28.04
6.7
11.7
mmol/l
1.3
1.1
0.74
40
59
(3002582) Erythrocytes [#/volume] in Urine
166
756
3.20
25.83
4.2
2.7
e6/l
38.2
54.0
0.41
141
552
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
114
413
3.56
25.83
4.7
3.0
ng/l
319.7
529.7
0.26
69
254
(3019309) Folate [Moles/volume] in Red Blood Cells
101
342
3.70
25.32
1.9
1.6
nmol/l
1110.6
1205.9
0.44
84
266
(42870588) Differential panel, method unspecified - Blood
187
934
3.06
24.41
7.1
5.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
35
49
7.80
24.17
2.0
1.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
166
779
3.08
24.17
3.3
3.0
mmol/l
2.3
2.4
1.41
152
696
(3026782) Osmolality of Urine
121
473
3.33
24.08
3.7
2.4
mosm/kgh2o
503.0
567.7
1.86
111
398
(3001604) Monocytes [#/volume] in Blood
247
1452
3.18
23.87
8.1
5.4
e9/l
0.6
0.5
5.01
221
1275
(3013115) Eosinophils [#/volume] in Blood
252
1500
3.21
23.79
9.3
5.8
e9/l
0.2
0.2
0.16
228
1335
(3006315) Basophils [#/volume] in Blood
247
1458
3.16
23.58
8.3
5.4
e9/l
0.0
0.0
0.38
221
1280
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
43
78
6.12
23.33
7.1
10.8
%
3.0
1.6
3.85
43
70
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
52
113
5.20
23.23
3.8
4.1
mmol/l
24.2
23.7
0.51
46
105
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
59
143
4.73
23.17
2.0
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
54
124
4.94
22.61
6.1
7.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
179
906
2.92
22.28
2.4
1.7
pmol/l
94.1
96.7
0.34
123
477
(3019198) Lymphocytes [#/volume] in Blood
250
1517
3.07
22.11
8.3
5.3
e9/l
2.2
2.0
2.49
226
1353
(3019150) Specific gravity of Urine by Refractometry
146
664
3.00
22.10
4.9
2.9
kg/l
1.0
1.0
1.20
13
71
(3013650) Neutrophils [#/volume] in Blood by Automated count
265
1668
3.16
21.80
15.2
8.0
e9/l
4.4
4.0
1.48
241
1456
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
167
829
2.87
21.35
5.2
3.0
ng/l
22.7
31.8
0.37
102
430
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
173
876
2.86
21.28
4.4
2.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
144
680
2.85
19.96
3.8
2.6
e6/l
0.4
0.3
0.22
119
485
(3018095) Leukocytes [#/volume] in Urine
177
931
2.75
19.90
5.5
3.2
e6/l
31.8
52.5
0.51
145
596
(3000850) Epithelial cells [#/volume] in Urine
118
503
2.99
19.73
3.2
2.3
e6/l
9.5
8.9
0.10
103
437
(3026008) Bacteria identified in Urine by Culture
151
750
2.73
18.76
3.7
2.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
25
32
8.31
18.51
2.4
2.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
315
2291
3.79
18.44
5.8
3.9
pmol/l
14.0
14.5
2.82
300
2107
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
304
2169
3.44
18.25
7.4
3.0
u/l
55.5
39.2
2.98
296
2073
(3007853) Bacteria identified in Skin by Aerobe culture
83
301
3.28
18.19
1.9
1.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
94
374
3.04
17.55
3.5
2.5
e6/l
7.0
3.4
1.45
55
184
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
66
213
3.56
17.35
4.9
2.9
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
82
304
3.19
17.27
3.9
3.5
umol/l
4.9
8.5
1.58
71
263
(44816559) Phosphatidylethanol [Mass/volume] in Blood
40
90
4.87
17.04
1.6
1.3
—
—
—
0
0
(3039000) Anion gap in Blood
28
47
6.37
16.30
7.8
15.5
mmol/l
11.1
11.1
0.00
28
41
(3018572) Chloride [Moles/volume] in Blood
28
47
6.37
16.30
7.8
15.5
mmol/l
105.4
105.4
0.01
28
41
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
42
103
4.48
16.10
2.1
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
135
676
2.58
16.03
7.9
6.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
69
244
3.26
15.62
3.9
2.2
u/l
35.0
30.5
0.19
60
200
(36304419) Bacteria [Presence] in Urine
134
687
2.50
14.96
3.8
2.5
—
—
—
0
0
(3044889) 12 lead EKG panel
257
1764
2.55
14.91
4.6
3.1
—
—
—
0
0
(3009343) pH of Capillary blood
49
144
3.78
14.71
2.9
4.3
ph
7.4
7.4
—
10
15
(3037467) Urinalysis macro (dipstick) panel - Urine
280
2010
2.70
14.64
5.9
3.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
48
140
3.80
14.56
2.9
4.4
mmol/l
1.5
1.6
0.05
33
102
(3009261) Glucose [Presence] in Urine by Test strip
223
1456
2.37
14.15
4.8
3.1
estimate
0.0
0.0
0.00
46
288
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
46
134
3.78
13.97
7.7
7.4
mmol/l
24.5
24.9
0.37
46
134
(3031040) Bacteria [#/volume] in Urine by Automated count
267
1894
2.54
13.95
7.0
3.6
e6/l
657.5
81.7
0.49
11
18
(3013707) Erythrocyte sedimentation rate by Westergren method
284
2074
2.68
13.95
4.8
3.7
mm/h
9.7
8.8
0.70
271
1919
(3035350) Ketones [Presence] in Urine by Test strip
220
1437
2.34
13.82
4.6
3.0
estimate
0.0
0.0
0.00
42
299
(3042936) Bacteria identified in Isolate by Culture
82
342
2.80
13.78
2.7
2.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
220
1443
2.33
13.60
5.9
4.2
estimate
0.0
0.0
0.00
46
301
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
13
10
13.44
13.43
2.2
2.0
umol/l
13.9
16.9
—
13
10
(3022948) Iron [Moles/volume] in Serum or Plasma
83
358
2.71
13.02
1.9
2.1
umol/l
11.9
14.4
2.20
75
325
(3023511) Choriogonadotropin [Units/volume] in Urine
50
165
3.35
12.56
2.0
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
22
38
6.10
12.41
4.5
3.0
%
17.6
16.7
0.54
16
18
(3019550) Sodium [Moles/volume] in Serum or Plasma
346
2887
5.01
12.20
33.1
10.9
mmol/l
139.3
139.6
1.72
341
2798
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
87
396
2.57
12.18
3.1
2.3
e6/l
0.9
0.9
0.08
48
209
(3023103) Potassium [Moles/volume] in Serum or Plasma
346
2893
4.96
12.02
32.8
10.9
mmol/l
3.9
3.9
0.40
340
2793
(3029937) Albumin [Presence] in Urine by Test strip
137
768
2.26
11.99
5.1
3.3
estimate
0.0
0.0
0.80
43
293
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
121
644
2.32
11.98
2.7
2.1
mg/l
2.7
2.8
0.28
111
549
(3021589) Normoblasts [#/volume] in Blood
199
1295
2.18
11.98
14.5
7.9
e9/l
0.0
0.0
0.91
162
1059
(1616796) Gas panel - Central venous blood
23
44
5.51
11.69
3.6
2.8
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
75
325
2.65
11.56
1.8
2.0
g/l
2.4
2.4
0.31
66
295
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
48
163
3.24
11.49
1.4
1.6
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
175
1104
2.13
11.18
2.6
2.3
nmol/l
64.3
72.8
3.76
168
1007
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
330
2718
3.29
10.85
7.7
4.5
mu/l
1.7
2.2
0.61
322
2548
(3017509) Phencyclidine [Presence] in Urine
14
5
29.02
10.80
4.1
1.0
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
56
217
2.87
10.66
2.7
2.7
%
1.8
1.7
0.09
50
196
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
327
2687
3.13
10.65
5.9
3.5
mmol/l
6.2
5.7
4.34
316
2490
(21494755) Public health laboratory ask at order entry panel
9
462
0.17
10.47
1.2
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
21
41
5.37
10.44
2.8
2.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
66
282
2.64
10.41
3.3
2.4
u/l
3996.3
5157.9
0.11
16
132
(3011397) Hemoglobin [Presence] in Urine by Test strip
115
632
2.20
10.31
3.8
3.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
106
565
2.24
10.24
4.2
4.2
mg/mmol
2.8
14.7
4.11
65
380
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
67
292
2.59
10.14
1.7
2.1
%
18.7
24.6
2.30
53
252
(3017143) Hepatitis C virus Ab [Presence] in Serum
99
515
2.27
10.13
2.3
1.6
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
21
43
5.12
9.91
6.8
3.3
kpa
9.1
9.2
0.10
21
43
(3013290) Carbon dioxide [Partial pressure] in Blood
21
44
5.00
9.66
6.8
3.3
kpa
5.2
5.1
0.54
21
44
(3012501) Base excess in Blood by calculation
21
44
5.00
9.66
6.8
3.3
mmol/l
2.4
2.4
0.01
15
32
(3013512) EKG study
108
597
2.15
9.43
6.3
3.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
109
617
2.09
8.88
2.2
1.8
mg/l
1.0
0.9
0.19
82
454
(3012516) Albumin [Mass/volume] in Urine
98
534
2.14
8.81
3.4
3.5
mg/l
785.7
334.4
0.25
58
361
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
18
37
5.07
8.45
1.4
1.6
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
18
37
5.07
8.45
1.4
1.6
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
53
228
2.55
8.18
6.8
16.6
inr
1.0
1.2
—
9
40
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
88
473
2.13
8.13
2.8
2.9
ng/l
1040.6
671.8
0.50
75
375
(3023520) Reticulocytes [#/volume] in Blood
40
150
2.87
8.04
2.4
2.8
e9/l
70.3
71.1
0.04
31
110
(3044242) Glucose [Moles/volume] in Arterial blood
10
12
8.54
7.61
2.3
7.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
26
78
3.51
7.53
1.2
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
164
1132
1.82
7.10
5.3
3.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
49
218
2.44
7.03
2.6
1.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
294
2440
2.07
6.96
6.6
4.4
mmol/mol
40.2
38.0
2.12
276
2309
(3022313) Gas panel - Capillary blood
30
105
3.02
6.81
2.7
5.0
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
48
215
2.42
6.78
5.3
4.2
%
1.4
0.7
0.54
12
61
(3020891) Body temperature
25
80
3.28
6.57
8.0
4.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
18
46
4.06
6.52
4.1
4.0
u/ml
0.4
0.3
—
7
30
(3007566) Smooth muscle Ab [Titer] in Serum
26
86
3.18
6.48
1.1
1.3
titre
43.3
60.0
—
6
5
(46235355) HIV 1 and 2 tests - Meaningful Use set
153
1063
1.76
6.28
2.6
2.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
121
789
1.80
6.14
2.4
2.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
61
316
2.12
6.10
1.4
1.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
24
79
3.18
6.04
2.1
1.9
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
347
3136
3.28
5.97
18.7
8.3
u/l
29.1
26.8
1.08
340
3044
(3002385) Erythrocyte distribution width [Ratio]
308
2665
2.01
5.54
35.7
12.5
%
13.7
13.4
3.58
303
2622
(3021440) Promyelocytes/100 leukocytes in Blood
43
201
2.29
5.52
5.8
4.3
%
0.2
0.2
—
10
55
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
127
864
1.72
5.45
2.6
2.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
10
18
5.68
5.35
1.8
1.4
%
9.9
12.0
—
10
18
(3006653) Thiamine [Moles/volume] in Blood
9
8
11.49
5.32
1.6
1.9
nmol/l
159.2
156.5
—
9
8
(3000494) Fungus identified in Specimen by Culture
54
283
2.07
5.22
1.8
1.5
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
8
6
13.59
5.10
1.3
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
319
2817
2.07
5.08
4.9
3.8
mmol/l
2.7
2.8
1.84
301
2648
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
9
10.22
5.05
2.6
4.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
9
10.22
5.05
2.6
4.0
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
22
77
2.98
5.02
1.1
1.2
e6/l
1.4
6.4
0.74
17
59
(3030905) Polymorphonuclear cells [#/volume] in Blood
18
56
3.33
4.96
2.4
3.2
e9/l
3.8
4.3
0.40
18
56
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
120
823
1.68
4.92
1.4
1.3
u/ml
1.0
1.8
0.47
30
221
(3005719) IgG [Mass/volume] in Serum or Plasma
44
218
2.16
4.92
1.4
2.1
g/l
10.2
10.3
0.09
38
199
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
18
57
3.27
4.83
2.5
3.3
%
56.2
56.0
0.03
18
57
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
335
3031
2.32
4.73
30.6
10.5
mg/l
20.1
20.8
0.17
300
2316
(3002179) Metamyelocytes/100 leukocytes in Blood
41
201
2.17
4.70
4.2
4.0
%
0.9
0.4
—
9
44
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
304
2665
1.85
4.61
24.1
9.1
ml/min/173m2
97.1
93.5
1.97
248
2103
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
304
2668
1.85
4.55
4.3
3.3
mmol/l
1.6
1.3
5.34
287
2507
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
17
55
3.19
4.42
3.6
2.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
122
860
1.63
4.42
3.1
2.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
122
861
1.63
4.39
4.7
2.7
—
—
—
0
0
(44806118)
11
26
4.33
4.38
1.6
1.6
—
—
—
0
0
(44790047)
11
26
4.33
4.38
1.6
1.6
—
—
—
0
0
(44790049)
11
26
4.33
4.38
1.6
1.6
—
—
—
0
0
(44790048)
11
26
4.33
4.38
1.6
1.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
20
72
2.88
4.36
3.7
2.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
39
194
2.13
4.32
6.3
4.4
%
0.0
0.0
—
8
49
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
100
676
1.66
4.25
1.7
1.7
mmol/l
1.8
1.4
2.50
86
589
(3035285) Chloride [Moles/volume] in Venous blood
10
23
4.44
4.11
3.0
2.7
mmol/l
106.4
106.1
—
10
23
(3041354) Potassium [Moles/volume] in Venous blood
10
23
4.44
4.11
3.0
2.7
mmol/l
3.9
3.9
—
10
23
(40760892) CBC W Ordered Manual Differential panel - Blood
108
751
1.62
4.09
6.4
3.9
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
312
2785
1.84
4.08
4.8
3.6
mmol/l
4.6
4.7
0.78
297
2630
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
8
257
0.30
4.03
1.3
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
17
59
2.97
3.95
1.1
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
25
107
2.44
3.93
2.2
2.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
28
127
2.31
3.88
1.3
1.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
8
11
7.41
3.88
2.0
7.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
47
261
1.92
3.87
1.2
1.3
iu/ml
59.2
173.2
2.72
17
101
(3048689) Calprotectin [Mass/mass] in Stool
73
466
1.71
3.81
2.1
2.6
ug/g
67.7
107.2
1.63
58
358
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
175
1376
1.52
3.81
7.0
4.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
7
8
8.89
3.79
2.3
2.0
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
6
5
12.17
3.77
3.8
9.0
mmol/l
23.9
25.9
—
6
5
(3022621) pH of Urine by Test strip
32
156
2.15
3.74
4.7
2.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
25
4.08
3.72
1.0
1.2
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
22
93
2.45
3.56
2.1
2.9
g/l
3.7
3.5
0.12
22
88
(3034770) Mitochondria Ab [Titer] in Serum
22
93
2.45
3.56
1.2
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
67
431
1.68
3.39
2.6
1.8
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
20
428
0.44
3.38
1.6
1.5
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
12
37
3.32
3.37
1.1
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
64
408
1.69
3.35
1.4
1.4
titre
274.3
475.2
—
7
84
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
15
357
0.40
3.28
1.1
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
102
733
1.54
3.27
1.5
1.4
g/l
2.3
2.2
0.29
64
449
(3005322) IgE [Units/volume] in Serum or Plasma
36
195
1.94
3.20
1.8
1.3
u/ml
396.7
338.6
0.08
31
177
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
9
246
0.35
3.19
1.7
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
307
2778
1.67
3.18
4.6
3.6
mmol/l
1.3
1.4
4.18
293
2614
(3023419) Bacteria identified in Sputum by Culture
10
29
3.52
3.07
2.9
2.6
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
6
8
7.60
3.06
1.3
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
29
523
0.52
3.01
1.6
1.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
9
21
4.37
3.01
1.1
1.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
12
40
3.07
3.00
1.1
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
77
529
1.58
2.99
2.7
1.9
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
5
5
10.11
2.98
1.6
1.2
u/l
8.4
7.6
—
5
5
(3013139) Helicobacter pylori Ag [Presence] in Stool
32
171
1.96
2.97
1.2
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
52
324
1.71
2.96
1.2
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
179
1471
1.43
2.84
3.6
2.7
ug/l
90.8
84.0
0.24
169
1378
(3033705) Calcium.ionized [Moles/volume] in Venous blood
9
23
3.99
2.79
3.1
2.7
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
58
379
1.63
2.76
3.1
2.5
mmol/l
2.4
2.4
0.07
50
322
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
24
3.82
2.69
2.1
1.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
48
303
1.67
2.61
1.2
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
16
68
2.42
2.59
1.1
1.3
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
6
11
5.52
2.55
1.8
1.3
u/l
285.0
231.4
—
6
11
(3001019) Free T4 and TSH panel - Serum or Plasma
9
220
0.39
2.53
1.8
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
43
266
1.70
2.52
4.3
3.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
189
0.36
2.49
1.4
1.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
45
2.72
2.47
1.5
1.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
16
70
2.34
2.45
1.7
1.4
ug/g
277.3
299.7
—
9
40
(40761511) CBC panel - Blood by Automated count
340
3210
1.90
2.44
27.4
9.8
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
14
58
2.47
2.40
1.0
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
110
849
1.42
2.39
2.1
1.7
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
34
200
1.77
2.38
2.9
2.2
e9/l
4.9
3.9
1.57
28
173
(3021788) Differential panel - Synovial fluid
8
22
3.69
2.37
1.8
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
14
59
2.43
2.32
1.2
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
19
92
2.12
2.31
2.3
2.2
—
—
—
0
0
(4306422)
14
60
2.39
2.24
1.1
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
10
36
2.83
2.22
1.0
2.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
14
4.34
2.16
1.5
1.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
13
55
2.41
2.14
1.0
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
10
37
2.75
2.12
1.2
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
10
37
2.75
2.12
1.6
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
58
0.00
2.05
0.0
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
9
32
2.86
2.01
1.4
1.5
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
11
4.59
1.94
1.0
1.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
11
4.59
1.94
1.0
1.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
27
3.01
1.94
3.8
3.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
10
224
0.43
1.94
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
10
224
0.43
1.94
1.4
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
10
39
2.61
1.93
2.0
1.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
10
223
0.43
1.92
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
10
223
0.43
1.92
1.4
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
8
181
0.43
1.87
1.4
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
8
184
0.42
1.86
1.5
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
13
59
2.25
1.86
1.5
1.7
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
12
4.21
1.83
1.0
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
13
60
2.21
1.80
3.6
1.6
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
9
36
2.54
1.75
1.1
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
8
180
0.43
1.74
1.4
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
13
61
2.17
1.73
1.5
1.7
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
5
13
3.88
1.72
2.0
2.8
umol/l
29.4
26.8
—
5
13
(3036782) Glucose [Moles/volume] in Pleural fluid
5
13
3.88
1.72
1.4
1.1
mmol/l
7.0
6.8
—
5
13
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
31
197
1.63
1.69
1.2
1.3
—
20.7
—
0
11
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
8
31
2.62
1.67
1.5
1.6
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
6
19
3.19
1.67
1.2
1.3
mmol/l
5.3
6.9
—
6
19
(3003327) Ova and parasites identified in Stool by Light microscopy
21
120
1.80
1.66
1.8
1.6
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
5
14
3.61
1.62
2.0
1.0
e6/l
12204.0
44059.6
—
5
7
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
32
2.53
1.60
1.0
1.6
nmol/l
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
8
32
2.53
1.60
1.1
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
11
220
0.48
1.60
1.5
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
16
281
0.55
1.56
1.2
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
18
100
1.84
1.56
4.9
2.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
29
186
1.61
1.54
1.2
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
5
15
3.36
1.53
1.0
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
27
2.62
1.52
1.1
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
11
51
2.19
1.52
6.0
3.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
30
195
1.59
1.51
1.3
1.4
iu/l
21.6
19.7
0.13
24
164
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
38
262
1.50
1.49
10.1
5.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
16
87
1.88
1.48
2.3
1.9
—
—
—
0
0
(4211845)
5
16
3.15
1.44
3.4
1.8
—
—
—
0
0
(3022145) Colonoscopy Study observation
40
282
1.47
1.41
1.3
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
81
647
1.32
1.38
3.3
2.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
19
112
1.73
1.38
1.8
1.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
75
596
1.33
1.33
2.4
2.5
umol/l
340.7
4041.5
1.53
64
530
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
12
62
1.97
1.29
1.1
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
35
2.31
1.27
1.0
1.6
—
—
—
0
0
(4027681)
6
25
2.42
1.25
1.7
1.3
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
19
116
1.67
1.24
1.2
1.7
—
10.1
—
0
5
(3024522) Salmonella sp identified in Specimen by Organism specific culture
8
37
2.19
1.22
1.1
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
8
37
2.19
1.22
1.3
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
8
37
2.19
1.22
1.3
1.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
19
2.65
1.22
1.2
2.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
28
190
1.51
1.20
4.1
3.0
—
—
—
0
0
(3019225) pH of Specimen
29
199
1.50
1.19
6.1
4.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
7
31
2.28
1.11
1.4
1.7
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
21
2.40
1.09
1.0
1.2
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
7
32
2.21
1.08
1.3
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
10
52
1.95
1.07
2.3
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
12
67
1.82
1.06
1.8
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
16
99
1.64
1.01
1.3
1.7
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
17
107
1.62
1.01
1.7
3.3
g/l
0.1
0.3
—
7
52
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
35
2.02
1.00
1.0
1.9
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
25
174
1.47
0.98
2.4
1.9
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
36
1.96
0.97
1.1
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
64
521
1.28
0.97
1.4
1.2
iu/ml
11.7
28.8
2.85
16
154
(3017446) Testosterone [Moles/volume] in Serum or Plasma
34
252
1.39
0.96
2.2
2.2
nmol/l
10.5
13.3
0.87
27
234
(3008898) HLA-B27 [Presence]
25
175
1.46
0.96
1.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
51
1.78
0.95
1.2
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
27
2.24
0.94
1.0
1.0
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
351
3433
1.63
0.93
43.7
15.3
e9/l
264.5
257.3
1.32
345
3357
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
61
496
1.28
0.93
1.2
1.2
u/ml
1.2
8.1
2.65
15
195
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
28
2.16
0.92
1.0
2.0
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
12
71
1.71
0.90
1.3
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
6
29
2.09
0.89
2.7
1.1
—
—
—
0
0
(3035941) MCH [Entitic mass]
351
3436
1.60
0.88
43.5
15.2
pg
30.1
30.1
0.07
346
3395
(3024731) MCV [Entitic volume]
351
3436
1.60
0.88
43.5
15.3
fl
90.1
90.0
0.23
346
3396
(3005570) Glucose [Moles/volume] in Urine
6
30
2.02
0.87
1.2
2.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
30
2.02
0.87
1.2
1.3
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
351
3437
1.59
0.87
43.6
15.3
e12/l
4.5
4.6
3.44
344
3353
(3014765) Yersinia sp identified in Stool by Organism specific culture
15
96
1.59
0.85
1.1
1.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
351
3439
1.58
0.84
43.8
15.4
e9/l
7.3
6.7
5.71
344
3353
(3000963) Hemoglobin [Mass/volume] in Blood
351
3439
1.58
0.84
44.0
15.4
g/l
134.1
137.2
3.46
346
3400
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
32
1.89
0.82
1.2
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
6
32
1.89
0.82
1.0
1.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
15
98
1.55
0.79
1.1
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
39
307
1.30
0.77
1.3
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
25
2.01
0.73
1.4
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
25
2.01
0.73
1.4
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
25
2.01
0.73
1.4
1.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
74
634
1.21
0.73
3.1
3.9
ug/l
0.9
1.7
6.22
65
578
(3024891) Influenza virus A+B Ag [Presence] in Specimen
15
101
1.51
0.71
1.1
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
26
1.94
0.71
1.2
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
26
1.94
0.71
1.4
1.2
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
41
1.72
0.70
1.7
5.5
—
4490.3
—
0
6
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
27
1.86
0.68
1.2
1.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
10
62
1.63
0.65
2.2
1.8
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
14
95
1.49
0.65
1.1
1.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
5
29
1.73
0.64
1.2
1.1
pmol/l
219.4
351.8
—
5
24
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
29
1.73
0.64
1.2
1.6
pg
31.6
32.9
—
5
29
(3029075) Extractable nuclear Ab panel - Serum
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(4035726)
13
185
0.69
0.60
1.5
1.4
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
22
0.00
0.59
0.0
3.4
—
61.4
—
0
22
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
53
1.52
0.58
1.4
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
15
106
1.43
0.58
1.8
1.7
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
23
0.00
0.58
0.0
1.7
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
6
35
1.73
0.58
1.2
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
35
1.73
0.58
1.0
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
36
1.68
0.57
1.3
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
37
1.63
0.56
1.3
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
37
1.63
0.56
1.3
1.5
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
96
0.62
0.53
1.2
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
101
1107
0.88
0.50
2.2
1.9
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
7
47
1.50
0.48
1.4
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
48
1.47
0.47
1.0
1.9
—
—
—
0
0
(4268621)
7
48
1.47
0.47
2.9
2.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
129
0.69
0.44
1.6
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
11
78
1.42
0.43
1.5
1.4
u/ml
129.4
105.9
—
5
14
(4010399)
24
194
1.25
0.43
1.4
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
31
1.62
0.43
1.2
1.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
32
1.57
0.42
1.0
1.5
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
32
1.57
0.42
1.4
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
28
232
1.22
0.41
1.3
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
34
1.48
0.40
1.0
1.7
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
8.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
36
1.39
0.38
1.6
1.6
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
11
81
1.37
0.36
1.5
1.4
—
—
—
0
0
(4034850)
12
90
1.34
0.36
10.1
10.8
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
77
0.64
0.36
1.0
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
245
2526
0.91
0.35
4.5
3.8
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
14
109
1.30
0.34
1.8
2.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
45
1.34
0.34
1.3
1.8
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
33
379
0.86
0.32
1.8
2.6
ug/l
0.8
0.7
0.11
28
213
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
11
83
1.34
0.32
1.5
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
26
221
1.19
0.31
1.1
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
13
164
0.79
0.31
1.3
1.5
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
7
52
1.35
0.31
1.1
2.1
g/l
0.8
0.8
—
7
43
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
46
507
0.89
0.26
2.8
3.7
%
20.3
20.9
0.10
13
198
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
6
81
0.74
0.24
1.2
1.2
—
10.3
—
0
10
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
6
81
0.74
0.24
1.0
1.2
—
3.2
—
0
8
(1761868) Lipid panel - Serum or Plasma
106
1116
0.93
0.23
3.3
2.2
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
10
0.00
0.21
0.0
2.8
—
—
—
0
0
(3024471) HLA-A [Type]
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
10
0.00
0.21
0.0
5.6
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
10
0.00
0.21
0.0
2.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
12
0.00
0.21
0.0
2.0
—
92.9
—
0
12
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
43.3
—
0
13
(3035933) Granulocytes/100 leukocytes in Blood
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
76
716
1.08
0.20
2.1
1.8
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(4024509)
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
51
1.18
0.19
1.2
2.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
95
908
1.06
0.17
1.7
1.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
7
63
1.11
0.17
1.4
2.3
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
5
67
0.74
0.17
1.2
1.3
—
49.7
—
0
6
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
10
86
1.17
0.11
1.1
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
55
1.09
0.09
2.5
2.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
19
175
1.09
0.08
1.2
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
7
66
1.06
0.08
2.0
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
300
2979
1.04
0.08
30.7
10.9
%
39.5
40.7
1.56
198
2448
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
70
0.85
0.07
1.0
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
8
90
0.89
0.07
1.8
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
103
1051
0.97
0.06
1.6
1.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
9
105
0.85
0.06
1.7
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
12
109
1.10
0.06
1.3
2.6
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
11
101
1.09
0.04
1.3
1.0
—
10.5
—
0
11
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
43
419
1.03
0.03
1.6
1.9
—
—
—
0
0
(1002224) Polysomnography panel
16
162
0.99
0.00
1.1
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
17
172
0.99
0.00
2.0
2.2
ml/min/173m2
110.5
76.8
—
6
69
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
11
111
0.99
0.00
1.6
1.5
g/l
1.3
1.2
0.18
11
106
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
15
149
1.01
0.00
1.4
2.7
u/ml
18.1
34.8
1.08
15
144
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
65
651
1.00
0.00
1.6
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
103
0.97
0.00
1.2
1.1
—
—
—
0
0
(3000492) Spirometry study
31
314
0.99
0.00
1.6
1.4
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4094501)
6
64
0.94
0.00
1.2
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
3.3
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
2.6
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
3.6
—
0.6
—
0
5
(3020393) Adenovirus Ag [Presence] in Stool
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
7
78
0.90
0.00
1.3
5.9
mg/l
1.6
1.3
—
7
73
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
97
0.93
0.00
1.4
1.4
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
59
0.85
0.00
1.0
1.2
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
36.8
—
0
5
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
5.7
—
0
7
Mortality – FinRegistry
↥Association
Association between endpoint Z21_PREVIOUS_SUICIDE_ATTEMPT and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Z21_PREVIOUS_SUICIDE_ATTEMPT | 4.387 [3.26, 5.9] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.091 |
During the follow-up period (1.1.1998 — 31.12.2019), 166 out of 1423 females with Z21_PREVIOUS_SUICIDE_ATTEMPT died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Z21_PREVIOUS_SUICIDE_ATTEMPT | 4.765 [3.67, 6.19] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.261 |
During the follow-up period (1.1.1998 — 31.12.2019), 309 out of 1255 males with Z21_PREVIOUS_SUICIDE_ATTEMPT died.
Mortality risk
Mortality risk for people of age
years, who have Z21_PREVIOUS_SUICIDE_ATTEMPT.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.414% | 1.089% |
| 5 | 2.367% | 6.996% |
| 10 | 5.881% | 16.466% |
| 15 | 11.087% | 29.163% |
| 20 | 18.56% | 45.816% |
Relationships between endpoints
↥Index endpoint: Z21_PREVIOUS_SUICIDE_ATTEMPT – Previous suicide attempt
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data